Biomarkers in Transplant Recipients to Improve Outcomes

Recruiting now

Conditions studied: Solid Organ Transplantation, Bone Marrow Transplantation

In brief

The objective of this study is to evaluate whether certain proteins, expressed in biological tissues can indict a better understanding of the effect of drugs that are used to treat rejection, and of processes leading to rejection and rejection-free outcomes.

Key facts

Study ID

NCT01163578

Run by

University of Pittsburgh

People needed

1200

Starts

2005-03-01

Expected to finish

2030-03-01

Last updated by the study team

2026-08-10

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Recipients of abdominal, thoracic and bone marrow allografts that are receiving inpatient and outpatient follow-up with routine laboratory tests at the University of Pittsburgh Medical Center.
• All Ages
• Subject or parents are able to read and understand the informed consent

You may not qualify if…

• Subjects and/or their parents who are unable to read and understand informed consent.

Where it is running

• Children's Hospital of Pittsburgh of UPMC — Pittsburgh, Pennsylvania, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.